These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19032081)

  • 21. A chemogenomic approach to discovering target-selective drugs.
    Janzen WP; Hodge CN
    Chem Biol Drug Des; 2006 Jan; 67(1):85-6. PubMed ID: 16492154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prioritizing hits from phenotypic high-content screens.
    Low J; Stancato L; Lee J; Sutherland JJ
    Curr Opin Drug Discov Devel; 2008 May; 11(3):338-45. PubMed ID: 18428087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A screening study of ChirBase molecular database to explore the expanded chiral pool derived from the application of chiral chromatography.
    Piras P; Roussel C
    J Pharm Biomed Anal; 2008 Apr; 46(5):839-47. PubMed ID: 17942261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A relational learning approach to Structure-Activity Relationships in drug design toxicity studies.
    Camacho R; Pereira M; Costa VS; Fonseca NA; Adriano C; Simões CJ; Brito RM
    J Integr Bioinform; 2011 Sep; 8(3):182. PubMed ID: 21926445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel in silico approach to drug discovery via computational intelligence.
    Hecht D; Fogel GB
    J Chem Inf Model; 2009 Apr; 49(4):1105-21. PubMed ID: 19348414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated decision support for assessing chemical liabilities.
    Spjuth O; Eklund M; Ahlberg Helgee E; Boyer S; Carlsson L
    J Chem Inf Model; 2011 Aug; 51(8):1840-7. PubMed ID: 21774475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In silico toxicology for the pharmaceutical sciences.
    Valerio LG
    Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seeing small molecules in action with bioorthogonal chemistry.
    Raghavan AS; Hang HC
    Drug Discov Today; 2009 Feb; 14(3-4):178-84. PubMed ID: 18973827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioinformatics and cheminformatics: where do the twain meet?
    Sukumar N; Krein M; Breneman CM
    Curr Opin Drug Discov Devel; 2008 May; 11(3):311-9. PubMed ID: 18428084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mobile apps for chemistry in the world of drug discovery.
    Williams AJ; Ekins S; Clark AM; Jack JJ; Apodaca RL
    Drug Discov Today; 2011 Nov; 16(21-22):928-39. PubMed ID: 21924376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enantiomeric separation and determination of absolute stereochemistry of asymmetric molecules in drug discovery: building chiral technology toolboxes.
    McConnell O; Bach A; Balibar C; Byrne N; Cai Y; Carter G; Chlenov M; Di L; Fan K; Goljer I; He Y; Herold D; Kagan M; Kerns E; Koehn F; Kraml C; Marathias V; Marquez B; McDonald L; Nogle L; Petucci C; Schlingmann G; Tawa G; Tischler M; Williamson RT; Sutherland A; Watts W; Young M; Zhang MY; Zhang Y; Zhou D; Ho D
    Chirality; 2007 Sep; 19(9):658-82. PubMed ID: 17390370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolution of ADME science: where else can modeling and simulation contribute?
    Smith DA
    Mol Pharm; 2013 Apr; 10(4):1162-70. PubMed ID: 23294153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In silico drug profiling of the human kinome based on a molecular marker for cross reactivity.
    Zhang X; Fernández A
    Mol Pharm; 2008; 5(5):728-38. PubMed ID: 18620417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances in computer-aided drug design.
    Song CM; Lim SJ; Tong JC
    Brief Bioinform; 2009 Sep; 10(5):579-91. PubMed ID: 19433475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of data fusion methods in virtual screening: theoretical model.
    Whittle M; Gillet VJ; Willett P; Loesel J
    J Chem Inf Model; 2006; 46(6):2193-205. PubMed ID: 17125164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Form follows function: shape analysis of protein cavities for receptor-based drug design.
    Weisel M; Proschak E; Kriegl JM; Schneider G
    Proteomics; 2009 Jan; 9(2):451-9. PubMed ID: 19142949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent trends in library design: 'rational design' revisited.
    Schnur DM
    Curr Opin Drug Discov Devel; 2008 May; 11(3):375-80. PubMed ID: 18428091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In silico prediction of ionization constants of drugs.
    Lee PH; Ayyampalayam SN; Carreira LA; Shalaeva M; Bhattachar S; Coselmon R; Poole S; Gifford E; Lombardo F
    Mol Pharm; 2007; 4(4):498-512. PubMed ID: 17629304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimizing the use of open-source software applications in drug discovery.
    Geldenhuys WJ; Gaasch KE; Watson M; Allen DD; Van der Schyf CJ
    Drug Discov Today; 2006 Feb; 11(3-4):127-32. PubMed ID: 16533710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Machine learning models for lipophilicity and their domain of applicability.
    Schroeter T; Schwaighofer A; Mika S; Laak AT; Suelzle D; Ganzer U; Heinrich N; Müller KR
    Mol Pharm; 2007; 4(4):524-38. PubMed ID: 17637064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.